Product
Recombinant human Epidermal Growth Factor
1 clinical trial
3 indications
Indication
Foot UlcerIndication
DiabetesIndication
Epidermal Growth FactorClinical trial
Efficacy and Safety Evaluation of the Intralesional Recombinant Human Epidermal Growth Factor (rhEGF) in Subjects With Diabetic Foot Ulcer. Multicenter, Randomized, Double-blind, Placebo-controlled Study.Status: Active (not recruiting), Estimated PCD: 2019-12-01